The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition
about
The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
The JAK2V617F Point Mutation I ...... Susceptible to JAK2 Inhibition
@en
The JAK2V617F Point Mutation I ...... Susceptible to JAK2 Inhibition
@nl
type
label
The JAK2V617F Point Mutation I ...... Susceptible to JAK2 Inhibition
@en
The JAK2V617F Point Mutation I ...... Susceptible to JAK2 Inhibition
@nl
prefLabel
The JAK2V617F Point Mutation I ...... Susceptible to JAK2 Inhibition
@en
The JAK2V617F Point Mutation I ...... Susceptible to JAK2 Inhibition
@nl
P2093
P2860
P356
P1476
The JAK2V617F Point Mutation I ...... Susceptible to JAK2 Inhibition
@en
P2093
Constantinos Tilkeridis
Costas Tsatalas
Eleftheria Lamprianidi
Emmanouil Spanoudakis
Ioanna Bazdiara
Ioannis Kotsianidis
Menelaos Papoutselis
Xrisa Kordella
P2860
P304
P356
10.4084/MJHID.2018.058
P407
P577
2018-01-01T00:00:00Z